Singapore Institute of Advanced Medicine Utilizes SG$5.5 Million from Rights Issue; Shares Down 3%

MT Newswires
Jul 17

Singapore Institute of Advanced Medicine Holdings (SGX:9G2) has used around SG$5.5 million of the net proceeds raised from the issue of rights shares, as general working capital and for the repayment of a loan from a shareholder.

This is part of the funds raised from a rights cum warrants issue of SG$14.9 million, according to a filing to the Singapore stock exchange on Thursday.

Following these allocations, the company holds a remaining balance of SG$5.1 million for ongoing working capital needs. Additionally, the company has earmarked SG$3.8 million for critical system maintenance and software upgrades, along with SG$500,000 for system revamps and other capital expenditures.

The company's shares were down over 3% in Friday's trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10